[Gammagraphy with sucralfate labelled with technetium in esophagitis].
In previous studies it has been reported that, after being labeled with technetium, sucralfate, an useful drug in peptic diseases, can be used to detect peptic lesions of the digestive tract. In this work we report our experience with this technique in the diagnosis of esophagitis. 25 studies (11 controls and 14 patients) were undertaken. Sucralfate scintigraphy was normal in the 11 control studies, and abnormal in 10 out of 14 patients. Scintigraphy was abnormal in peptic as well as caustic lesions.
Gomollón
F
F
Servicio de Aparato Digestivo, Hospital Clínico Universitario de Zaragoza.
Prats
E
E
Ducons
J A
JA
García
R
R
Ferrer
S
S
Banzo
J
J
Sainz
R
R
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004941:Esophagitis / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D013392:Sucralfate
D015609:Organotechnetium Compounds; C038248:technetium Tc 99m sucralfate; D013392:Sucralfate
Gammagrafía con sucralfato marcado con tecnecio en la esofagitis.